1.646.889.1200|info@lifescipublicrelations.com

Valneva/Emergent BioSolutions’ Candidate Zika Vaccine Shows Early Clinical Promise

//Valneva/Emergent BioSolutions’ Candidate Zika Vaccine Shows Early Clinical Promise

Valneva/Emergent BioSolutions’ Candidate Zika Vaccine Shows Early Clinical Promise

A European/US company collaboration has reported encouraging safety and immunogenicity in early clinical studies with an alum-adjuvanted Zika vaccine based on inactivated whole virus.

By | 2018-11-26T11:02:08-04:00 November 22nd, 2018|News|Comments Off on Valneva/Emergent BioSolutions’ Candidate Zika Vaccine Shows Early Clinical Promise

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.